Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Evaluation of Alternative Exercise Treatments on Weight Loss in Overweight Women.
This study has been completed.
Sponsored by: University of Pittsburgh
Information provided by: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00177632
  Purpose

The purpose is to examine the additional effect of either yoga or resistance exercise on weight loss weight combined with a standard behavioral weight loss intervention.


Condition Intervention Phase
Obesity
Weight Loss
Behavioral: behavioral weight loss
Phase I
Phase II

MedlinePlus related topics: Exercise and Physical Fitness Obesity Weight Control
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Single Group Assignment
Official Title: Evaluation of Alternative Exercise Treatments on Weight Loss in Overweight Women.

Further study details as provided by University of Pittsburgh:

Primary Outcome Measures:
  • weight loss

Secondary Outcome Measures:
  • fitness
  • physical activity
  • dietary intake
  • mediators

Estimated Enrollment: 66
Study Start Date: July 2003
Estimated Study Completion Date: July 2004
  Eligibility

Ages Eligible for Study:   25 Years to 55 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Female
  2. 25-55 years of age
  3. BMI = 25-35 kg/m2
  4. Ability to provide informed consent.
  5. Ability to provide consent from their personal physician to participate in this study.

Exclusion Criteria:

  1. Participation in regular exercise (aerobic, yoga or resistance exercise) for > 20 minutes per day on > 2 days per week for the last 3 months. (This study is designed to recruit relatively sedentary adults.)
  2. Currently being treated for psychological disorders/conditions and/or currently taking psychotropic medication.
  3. Diabetes, hypothyroidism, or other medical conditions which would affect energy metabolism.
  4. Women who are currently pregnant, pregnant within the previous six months, or planning on becoming pregnant within the next 12 months. (Pregnancy during initial screening will be based on self-report and will be included on the detailed medical history that is completed by subjects. However, pregnancy status will also be verified by the pregnancy test that is required for the baseline, 6 and 12 month DEXA).
  5. Non-medicated resting systolic blood pressure >160 mmHg or non-medicated resting diastolic blood pressure >100 mmHg, or taking medication that would affect blood pressure.
  6. Taking medication that would affect resting heart rate or the heart rate response during exercise (e.g., beta blockade).
  7. Arrhythmia on resting or exercise electrocardiogram that would indicate that vigorous exercise was contraindicated.
  8. History of myocardial infarction or valvular disease.
  9. History of orthopedic complications that would prevent optimal participation in the exercise component (e.g., heel spurs, severe arthritis).
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00177632

Locations
United States, Pennsylvania
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15203
Sponsors and Collaborators
University of Pittsburgh
Investigators
Principal Investigator: John M Jakicic, Ph.D. University of Pittsburgh
  More Information

Study ID Numbers: 0402119
Study First Received: September 13, 2005
Last Updated: September 13, 2005
ClinicalTrials.gov Identifier: NCT00177632  
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Body Weight
Signs and Symptoms
Obesity
Weight Loss
Body Weight Changes
Nutrition Disorders
Overnutrition
Overweight

ClinicalTrials.gov processed this record on January 16, 2009